Back to Search
Start Over
Systemic therapy for brain metastases
- Source :
- Critical Reviews in Oncology/Hematology. 142:44-50
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- Metastases from cells outside of the central nervous system are the most common cancer found in the brain and are commonly associated with poor prognosis. Although cancer treatment is improving overall, central nervous system metastases are becoming more prevalent and require finesse to properly treat. Physicians must consider the biology of the primary tumor and the complex neurological environment that the metastasis resides in. This can be further complicated by the fact that the practice of cancer management is constantly evolving and therapy that works outside of the blood-brain barrier may not be effective inside of it. Therefore, this review seeks to update the reader on recent advancements made on the three most common sources of brain metastases: lung cancer, breast cancer, and melanoma. Each of these malignancies has been the subject of intriguing and novel avenues of therapy which are reviewed here.
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Lung Neoplasms
Central nervous system
Breast Neoplasms
Cardiorespiratory Medicine and Haematology
Systemic therapy
Article
Metastasis
03 medical and health sciences
Breast cancer
Rare Diseases
0302 clinical medicine
Humans
Medicine
Oncology & Carcinogenesis
Lung cancer
Intensive care medicine
Melanoma
Lung
Cancer
Brain Neoplasms
business.industry
Neurosciences
Hematology
medicine.disease
Primary tumor
Brain Disorders
Brain Cancer
030104 developmental biology
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
business
Subjects
Details
- ISSN :
- 10408428
- Volume :
- 142
- Database :
- OpenAIRE
- Journal :
- Critical Reviews in Oncology/Hematology
- Accession number :
- edsair.doi.dedup.....8e54e68d6a6bc2ccc52e62237e4c7d1d
- Full Text :
- https://doi.org/10.1016/j.critrevonc.2019.07.012